168 related articles for article (PubMed ID: 4144336)
21. Is there a problem with inhaled long-acting beta-adrenergic agonists?
Nelson HS
J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
[TBL] [Abstract][Full Text] [Related]
22. Beta-agonists in the treatment of asthma in France.
Michel FB; Even P; Clauzel AM
Bull Eur Physiopathol Respir; 1985; 21(5):7s-11s. PubMed ID: 2865995
[No Abstract] [Full Text] [Related]
23. Beta-agonists--friends or foes?
Staudinger HW; Haas JF
Eur Respir J; 1992 Jul; 5(7):894-5, author reply 898-900. PubMed ID: 1354170
[No Abstract] [Full Text] [Related]
24. Asthma.
Cates C; FitzGerald JM
Clin Evid; 2002 Jun; (7):1325-43. PubMed ID: 12230750
[No Abstract] [Full Text] [Related]
25. [Role of particulate matter and small airways in treatment of asthma with inhalative fixcombinations].
Voshaar T
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S390-3. PubMed ID: 19941243
[No Abstract] [Full Text] [Related]
26. [Beta 2 agonists in asthma therapy should be reevaluated--concerning the dosage].
Larsson K
Lakartidningen; 1991 Oct; 88(44):3643-5. PubMed ID: 1682539
[No Abstract] [Full Text] [Related]
27. Regular beta-agonist therapy--the quality of the evidence.
Sears MR; Taylor DR
Eur Respir J; 1992 Jul; 5(7):896-7, author reply 898-900. PubMed ID: 1354171
[No Abstract] [Full Text] [Related]
28. Levalbuterol and racemic albuterol: are there therapeutic differences?
Ahrens R; Weinberger M
J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
[No Abstract] [Full Text] [Related]
29. [A new long-acting asthma spray. Preliminary wait-and-see attitude?].
Flaten O
Tidsskr Nor Laegeforen; 1993 May; 113(13):1610. PubMed ID: 8101664
[No Abstract] [Full Text] [Related]
30. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
31. Labeling changes for asthma drug salmeterol.
FDA Consum; 2003; 37(6):6. PubMed ID: 14983813
[No Abstract] [Full Text] [Related]
32. New developments in bronchodilator therapy.
Nelson HS
Curr Opin Pulm Med; 1996 Jan; 2(1):35-9. PubMed ID: 9363113
[TBL] [Abstract][Full Text] [Related]
33. Controversies in asthma therapy with theophylline and the beta 2-adrenergic agonists.
Kelly HW
Clin Pharm; 1984; 3(4):386-95. PubMed ID: 6147224
[TBL] [Abstract][Full Text] [Related]
34. [Asthma mortality: consequences for therapy?].
Solèr M; Perruchoud AP
Schweiz Med Wochenschr; 1993 Feb; 123(5):165-9. PubMed ID: 8094899
[TBL] [Abstract][Full Text] [Related]
35. [Confusing about asthma therapy].
Larsson K; Svedmyr N
Lakartidningen; 1993 Oct; 90(40):3414-5. PubMed ID: 7901463
[No Abstract] [Full Text] [Related]
36. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
37. [Asthma and inhalation therapy: the points of view of the patient and the therapist].
Huchon G
Allerg Immunol (Paris); 1993 Oct; 25(8):354-8. PubMed ID: 7903537
[No Abstract] [Full Text] [Related]
38. [Side effects of sympathomimetic drugs in patients with bronchial asthma].
Sil'vestrov VP; Bakulin MP
Klin Med (Mosk); 1983 Mar; 61(3):76-8. PubMed ID: 6133979
[No Abstract] [Full Text] [Related]
39. [beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study].
Riedl-Seifert R
Dtsch Med Wochenschr; 2007 Mar; 132(12):633; author reply 633-4. PubMed ID: 17357910
[No Abstract] [Full Text] [Related]
40. [Asthma therapy--too much or too little?].
von Wichert P
Dtsch Med Wochenschr; 1988 May; 113(20):799-800. PubMed ID: 2897278
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
